| 245 |
Dong-A releases Dutavan Plus Tab. for the treatment of hair loss and benign prostatic hyperplasia |
2018-11-01 |
| 244 |
Dong-A ST granted approval for post-opening stability of growth hormone ‘Growtropin’ |
2018-10-12 |
| 243 |
Dong-A ST submits application for authorization to market DA-3880, licensed out to Sanwa Kagaku Kenk |
2018-10-01 |
| 242 |
Dong-A ST holds the graduation ceremony for the ‘13th Environment & Life Loving Class for Youth’ |
2018-07-27 |
| 241 |
Dong-A ST hosts ‘13th Environment & Life Loving Class for Youth’ |
2018-07-23 |
| 240 |
Dong-A ST holds 5th Annual General Shareholders’ Meeting |
2018-03-27 |
| 239 |
Dong-A ST conducts ‘Action Contribution Campaign’ |
2018-02-28 |
| 238 |
Dong-A ST and Takeda Pharmaceuticals Korea host launch symposium for ‘Edarbi’, a hypertension treatm |
2018-02-23 |
| 237 |
Dong-A ST set to accelerate entry into Indonesian market |
2018-02-06 |
| 236 |
Dong-A ST signs joint development and licensing agreement for bispecific antibody cancer immunothera |
2018-01-24 |
